Ivosidenib (Compound)

Synonyms:Ivosidenib, 1448347-49-6, AG-120, Tibsovo, Ivosidenib [INN], AG120, Ivosidenib [USAN], Ivosidenib [WHO-DD], Q2PCN8MAM6, UNII-Q2PCN8MAM6, Ivosidenib [USAN:INN:WHO-DD], (2S)-N-[(1S)-1-(2-chlorophenyl)-2-[(3,3-difluorocyclobutyl)amino]-2-oxoethyl]-1-(4-cyanopyridin-2-yl)-N-(5-fluoropyridin-3-yl)-5-oxopyrrolidine-2-carboxamide, Glycinamide, 1-(4-cyano-2-pyridinyl)-5-oxo-L-prolyl-2-(2-chlorophenyl)-N-(3,3-difluorocyclobutyl)-N2-(5-fluoro-3-pyridinyl)-, (2S)-, (2S)-N-{(1S)-1-(2-chlorophenyl)-2-[(3,3-difluorocyclobutyl)amino]-2-oxoethyl}-1-(4-cyanopyridin-2-yl)-N-(5-fluoropyridin-3-yl)-5-oxopyrrolidine-2-carboxamide, (S)-N-((S)-1-(2-chlorophenyl)-2-((3,3-difluorocyclobutyl)amino)-2-oxoethyl)-1-(4-cyanopyridin-2-yl)-N-(5-fluoropyridin-3-yl)-5-oxopyrrolidine-2-carboxamide, RG120, ivosidenibum, Tibsovo (TN), IVOSIDENIB [MI], Ivosidenib (USAN/INN), GTPL9217, CHEMBL3989958, IVOSIDENIB [ORANGE BOOK], SCHEMBL15122512, EX-A992, CHEBI:145430, BDBM363689, DTXSID801027928, AMY38924, US9850277, Compound 176, MFCD29036964, NSC789102, s8206, CCG-270141, CS-5122, DB14568, NSC-789102, NCGC00476170-04, NCGC00476170-06, (S)-N-((S)-1-(2-chlorophenyl)-2-(3,3-difluorocyclobutylamino)-2-oxoethyl)-1-(4-cyanopyridin-2-yl)-N-, (S)-N-((S)-1-(2-chlorophenyl)-2-(3,3-difluorocyclobutylamino)-2-oxoethyl)-1-(4-cyanopyridin-2-yl)-N-(5-fluoropyridin-3-yl)-5-oxopyrrolidine-2-carboxamide, AC-32624, AS-35058, HY-18767, A14386, D11090, A900315, EN300-21623926, Q27895417, (2S)-1-(4-Cyano-2-pyridinyl)-5-oxo-L-prolyl-2-(2-chloroPh)-N-(3,3-difluorocyclobutyl)-N2-(5-fluoro-3-pyridinyl)-glycinamide, (2S)-2-(2-CHLOROPHENYL)-2-{1-[(2S)-1-(4-CYANOPYRIDIN-2-YL)-5-OXOPYRROLIDIN-2-YL]-N-(5-FLUOROPYRIDIN-3-YL)FORMAMIDO}-N-(3,3-DIFLUOROCYCLOBUTYL)ACETAMIDE, (S)-N-((S)-1-(2-chlorophenyl)-2-((3,3-difluorocyclobutyl)amino)-2-oxoethyl)-1-(4-cyanopyridin-2-yl)-N-(5-fluoropyridin-3-yl)-5-oxopyrrolidine-2-carboxamide;AG-120, N-{(1S)-1-(2-chlorophenyl)-2-[(3,3-difluorocyclobutyl)amino]-2-oxoethyl}-1-(4-cyanopyridin-2-yl)-N-(5-fluoropyridin-3-yl)-5-oxo-L-prolinamide

Pubchem:PUBCHEM:71657455

Id:389d119d-e3ff-56d1-81a0-a9b081628cc6

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Ivosidenib's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Ivosidenib.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Ivosidenib.

Results found

Linked to

	Label	Description
	BRD-K93073858-001-01-1 Substance (Entity type)	A Substance
	ivosidenib (e9d95dbc-37d4-4c46-bc5e-fc1980f00d18) Collection (Entity type)	Metadatata for ivosidenib
	DCSTRUCT ID 05292 Collection (Entity type)	DrugPage Collection: (DrugCentralID:05292; PubChem_CID:71657455, FILE=drugcentral_drug_05292.json)
	Ivosidenib positively regulates DMTF1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	etafenone in similarity relationship with Ivosidenib Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Ivosidenib negatively regulates ATF3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Ivosidenib negatively regulates FOSL2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Ivosidenib positively regulates SLC75A1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Ivosidenib negatively regulates AQP3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Ivosidenib positively regulates IGFBP2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS